68Ga-FAPI

You have access
⁶⁸Ga-FAPI-04 PET/CT in Non–Small Cell Lung Cancer: Accurate Evaluation of Lymph Node Metastasis and Correlation with Fibroblast Activation Protein Expression
Chongjiao Li, Qiongrong Chen, Yueli Tian, Jie Chen, Kui Xu, Zhiwei Xiao, Juan Zhong, Jianyuan Wu, Bing Wen and Yong He

Journal of Nuclear Medicine April 1, 2024, 65 (4) 527-532; DOI: https://doi.org/10.2967/jnumed.123.266806
Open Access
⁶⁸Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study
Ling Chen, Shan Zheng, Linying Chen, Sunwang Xu, Kunlin Wu, Lingjun Kong, Jiajie Xue, Xiangjin Chen, Weibing Miao and Youzhi Zhu

Journal of Nuclear Medicine December 1, 2023, 64 (12) 1899-1905; DOI: https://doi.org/10.2967/jnumed.123.266079
You have access
⁶⁸Ga-Labeled Fibroblast Activation Protein Inhibitor (⁶⁸Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the ⁶⁸Ga-FAPI PET Observational Trial
Lukas Kessler, Nader Hirmas, Kim M. Pabst, Rainer Hamacher, Justin Ferdinandus, Benedikt M. Schaarschmidt, Aleksandar Milosevic, Michael Nader, Lale Umutlu, Waldemar Uhl, Anke Reinacher-Schick, Celine Lugnier, David Witte, Marco Niedergethmann, Ken Herrmann, Wolfgang P. Fendler and Jens T. Siveke

Journal of Nuclear Medicine December 1, 2023, 64 (12) 1910-1917; DOI: https://doi.org/10.2967/jnumed.122.264827
You have access
Comparison of Baseline ⁶⁸Ga-FAPI and ¹⁸F-FDG PET/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib
Meiqi Wu, Yanyu Wang, Qiao Yang, Xuezhu Wang, Xu Yang, Haiqun Xing, Xinting Sang, Xiang Li, Haitao Zhao and Li Huo

Journal of Nuclear Medicine October 1, 2023, 64 (10) 1532-1539; DOI: https://doi.org/10.2967/jnumed.123.265712
You have access
Performance of ⁶⁸Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT in Evaluation of Erdheim–Chester Disease: A Comparison with ¹⁸F-FDG PET/CT
Jiangyu Ma, Qiao Yang, Li Huo, Jiawen Dai, Na Niu and Xinxin Cao

Journal of Nuclear Medicine September 1, 2023, 64 (9) 1385-1391; DOI: https://doi.org/10.2967/jnumed.123.265691
Open Access
The Added Value of ⁶⁸Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with ¹⁸F-FDG–Negative Findings
Bingxin Gu, Xiaoping Xu, Ji Zhang, Xiaomin Ou, Zuguang Xia, Qing Guan, Silong Hu, Zhongyi Yang and Shaoli Song

Journal of Nuclear Medicine June 1, 2022, 63 (6) 875-881; DOI: https://doi.org/10.2967/jnumed.121.262790
You have access
⁶⁸Ga-DOTA-FAPI-04 PET/MR in the Evaluation of Gastric Carcinomas: Comparison with ¹⁸F-FDG PET/CT
Chunxia Qin, Fuqiang Shao, Yongkang Gai, Qingyao Liu, Weiwei Ruan, Fang Liu, Fan Hu and Xiaoli Lan

Journal of Nuclear Medicine January 1, 2022, 63 (1) 81-88; DOI: https://doi.org/10.2967/jnumed.120.258467
You have access
Fibroblast Activation Protein–Targeted PET/CT with ⁶⁸Ga-FAPI for Imaging IgG4-Related Disease: Comparison to ¹⁸F-FDG PET/CT
Yaping Luo, Qingqing Pan, Huaxia Yang, Linyi Peng, Wen Zhang and Fang Li

Journal of Nuclear Medicine February 1, 2021, 62 (2) 266-271; DOI: https://doi.org/10.2967/jnumed.120.244723

Main menu

User menu

Search

68Ga-FAPI